BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32634835)

  • 21. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical outcomes of early-stage small-cell lung cancer: single-center experience.
    Sayan M; Satir Turk M; Celik A; Cuneyt Kurul I; Irfan Tastepe A
    Asian Cardiovasc Thorac Ann; 2019 Mar; 27(3):187-191. PubMed ID: 30661378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?
    Luzzi L; Voltolini L; Campione A; Paladini P; Ghiribelli C; Di Bisceglie M; Gotti G
    J Cardiovasc Surg (Torino); 2003 Feb; 44(1):119-23. PubMed ID: 12627083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
    Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
    Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
    Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
    Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer.
    Moroga T; Yamashita S; Tokuishi K; Miyawaki M; Anami K; Yamamoto S; Kawahara K
    Ann Thorac Cardiovasc Surg; 2012; 18(2):89-94. PubMed ID: 22082811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.
    Ikeda K; Nomori H; Mori T; Kobayashi H; Iwatani K; Yoshimoto K
    J Thorac Oncol; 2006 Nov; 1(9):949-52. PubMed ID: 17409977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
    Matsuoka K; Sumitomo S; Misaki N
    J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.